Skip to main content
Caplight Logo









CoSyne Therapeutics

CoSyne Therapeutics

Private
LondonHealthcare & Life Scienceshttps://www.cosyne.com/

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CoSyne Therapeutics is a biotechnology company that utilizes polymathic AI and computational systems biology to discover and develop precision medicines for underserved brain diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoverybiotechnologyprecision medicineAI drug discoverycomputational biologyCRISPRibiology foundation modelstarget identificationbiotech AIin silico drug discoverysingle-cell analysiscompanion biomarkersneurological therapeuticsdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CoSyne Therapeutics Comparables

Compare CoSyne Therapeutics with similar companies based on industry and business-model similarity.

CoSyne Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Algen Biotechnologies
83%
Verge Labs
80%
1910 Genetics
80%

CoSyne Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Liisi Laaniste

Chief Scientific Officer & Co-Founder

Founding Team

Louwai Muhammed

Chief Executive Officer and Co-Founder

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 228% MoM, reaching 2.4K.

  • Mar 2, 2026

    Monthly visitors increased 36% to 2.4K.

CoSyne Therapeutics Filings

Explore SEC and related filing metadata, where available.

CoSyne Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CoSyne Therapeutics's valuation, stock price, and market status.

Is CoSyne Therapeutics a public or private company?

CoSyne Therapeutics is a private company.

What is the current stock price of CoSyne Therapeutics?

CoSyne Therapeutics is a private company with no public stock price. Caplight tracks CoSyne Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is CoSyne Therapeutics worth (valuation)?

Valuation information for CoSyne Therapeutics is not publicly available.

Can I buy CoSyne Therapeutics stock?

CoSyne Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CoSyne Therapeutics's last funding round?

Funding round information for CoSyne Therapeutics is not publicly available.

Who are the main investors in CoSyne Therapeutics?

Investor information for CoSyne Therapeutics is not publicly disclosed.

Will CoSyne Therapeutics IPO soon?

No public IPO plans have been announced for CoSyne Therapeutics.

How can I track CoSyne Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CoSyne Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range13
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?